Assignee
ONL THERAPEUTICS INC
US·4 granted patents·13 pending applications·6 citations·filing 2016–2025
Top patents by PatentIndex Score
17 records- 0188US10508134B2Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2016·Granted Dec 17, 2019·4 cites·24 claims
- 0284US10829518B2Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2019·Granted Nov 10, 2020·2 cites·22 claims
- 0380US12258425B2Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·0 cites·4 claims
- 0475US2025099554A1Compositions and methods of fas inhibitionONL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0573US2025346631A1Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0670US11597749B2Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2020·Granted Mar 7, 2023·0 cites·16 claims
- 0769US2024156898A1Methods and compositions for treating ocular disorders and diseasesONL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0865US2024197815A1Methods and compositions for improving visual function in ocular diseases and disordersONL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0964US2026062449A1Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1064US2026049106A1Peptide compositions and methods of useONL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1163US2024285724A1Methods and compositions for treating ocular disorders and diseasesONL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1262US2025163131A1Sfasl for inhibiting rpe cell death and associated disordersONL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1361US2023338470A1Methods and compositions for treating ocular disorders with fasrONL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1461US2024299488A1Methods and compositions for improving visual function in ocular diseases and disordersONL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1556US2021260168A1Compositions and methods of fas inhibitionONL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1647US2019201500A1Compositions and methods of fas inhibitionONL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1747US2025360123A1Methods and compositions for treating inherited retinal degenerationONL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →